The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with β-branched amino acids
Open accessAbstract
An important component of triple-drug anti-AIDS therapy is 2′,3′-dideoxy-3′-thiacytidine (3TC, lamivudine). Single mutations at residue 184 of the reverse transcriptase (RT) in HIV cause high-level resistance to 3TC and contribute to the failure of anti-AIDS combination therapy. We have determined crystal structures of the 3TC-resistant mutant HIV-1 RT (M184I) in both the presence and absence of a DNA/DNA template-primer. In the absence of a DNA substrate, the wild-type and mutant structures are very similar. However, comparison of crystal structures of M184I mutant and wild-type HIV-1 RT with and without DNA reveals repositioning of the template-primer in the M184I/DNA binary complex and other smaller changes in residues in the dNTP-binding site. On the basis of these structural results, we developed a model that explains the ability of the 3TC-resistant mutant M184I to incorporate dNTPs but not the nucleotide analog 3TCTP. In this model, steric hindrance is expected for NRTIs with β- or l - ring configurations, as with the enantiomer of 3TC that is used in therapy. Steric conflict between the oxathiolane ring of 3TCTP and the side chain of β-branched amino acids (Val, Ile, Thr) at position 184 perturbs inhibitor binding, leading to a reduction in incorporation of the analog. The model can also explain the 3TC resistance of analogous hepatitis B polymerase mutants. Repositioning of the template-primer as observed in the binary complex (M184I/DNA) may also occur in the catalytic ternary complex (M184I/DNA/3TCTP) and contribute to 3TC resistance by interfering with the formation of a catalytically competent closed complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Huang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202
Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6320 · Cited by 1,115
Self-citationA Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
Dienstag, J. L., Perrillo, R. P., Schiff, E. R., Bartholomew, M., Vicary, C., & Rubin, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332501 · Cited by 800
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
Allen, M. I., Deslauriers, M., Andrews, W. C., Tipples, G. A., Walters, K.-A., Tyrrell, D. L., Brown, N., & Condreay, L. D. (1998) · Hepatology · doi:10.1002/hep.510270628 · Cited by 793
Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase
St. Clair, M. H., Martin, J. L., Tudor-Williams, G., Bach, M. C., Vavro, C. L., King, D. M., Kellam, P., Kemp, S. D., & Larder, B. A. (1991) · Science · doi:10.1126/science.1716788 · Cited by 679
Tisdale, M., Kemp, S. D., Parry, N. R., & Larder, B. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5653 · Cited by 603
Origins and evolutionary relationships of retroviruses
Doolittle, R. F., Johnson, M. S., & McClure, M. A. (1989) · The Quarterly Review of Biology · doi:10.1086/416128 · Cited by 577
Tantillo, C., Ding, J., Jacobo-Molina, A., Nanni, R. G., Boyer, P. L., Hughes, S. H., Pauwels, R., Andries, K., Janssen, P. A. J., & Arnold, E. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1665 · Cited by 518
Self-citationJohnson, M. S., McClure, M. A., Feng, D. F., Gray, J., & Doolittle, R. F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7648 · Cited by 480
Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors
Esnouf, R., Ren, J., Ross, C., Jones, Y., Stammers, D., & Stuart, D. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-303 · Cited by 442
Back, N. K., Nijhuis, M., Keulen, W., Boucher, C. A., Oude Essink, B. O., van Kuilenburg, A. B., van Gennip, A. H., & Berkhout, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00777.x · Cited by 406
Shirasaka, T., Kavlick, M. F., Ueno, T., Gao, W. Y., Kojima, E., Alcaide, M. L., Chokekijchai, S., Roy, B. M., Arnold, E., & Yarchoan, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2398 · Cited by 386
Self-citationThe structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.
Rodgers, D. W., Gamblin, S. J., Harris, B. A., Ray, S., Culp, J. S., Hellmig, B., Woolf, D. J., Debouck, C., & Harrison, S. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1222 · Cited by 378
Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides
Schinazi, R. F., Lloyd, R. M., Nguyen, M. H., Cannon, D. L., McMillan, A., Ilksoy, N., Chu, C. K., Liotta, D. C., Bazmi, H. Z., & Mellors, J. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.875 · Cited by 364
Ding, J., Das, K., Hsiou, Y., Sarafianos, S. G., Clark, A. D., Jacobo-Molina, A., Tantillo, C., Hughes, S. H., & Arnold, E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2208 · Cited by 321
Self-citationBoucher, C. A., Cammack, N., Schipper, P., Schuurman, R., Rouse, P., Wainberg, M. A., & Cameron, J. M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2231 · Cited by 313
Site-specific mutagenesis of AIDS virus reverse transcriptase
Larder, B. A., Purifoy, D. J. M., Powell, K. L., & Darby, G. (1987) · Nature · doi:10.1038/327716a0 · Cited by 312
Chen, C. H., Vazquez-Padua, M., & Cheng, Y. C. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11067-5 · Cited by 296
Schinazi, R. F., McMillan, A., Cannon, D., Mathis, R., Lloyd, R. M., Peck, A., Sommadossi, J. P., St Clair, M., Wilson, J., & Furman, P. A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2423 · Cited by 294
Hsiou, Y., Ding, J., Das, K., Clark, Jr., Hughes, S., & Arnold, E. (1996) · Structure · doi:10.1016/s0969-2126(96)00091-3 · Cited by 289
Self-citationGao, Q., Gu, Z., Parniak, M. A., Cameron, J., Cammack, N., Boucher, C., & Wainberg, M. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1390 · Cited by 228
HIV resistance to reverse transcriptase inhibitors
De Clercq, E. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90001-9 · Cited by 225
Boyer, P. L., Tantillo, C., Jacobo‐Molina, A., Nanni, R. G., Ding, J., Arnold, E., & Hughes, S. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4882 · Cited by 161
Self-citationKeulen, W., Back, N. K. T., van Wijk, A., Boucher, C. A., & Berkhout, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3346-3350.1997 · Cited by 152
Krebs, R., Immendoerfer, U., Thrall, S. H., Wöhrl, B. M., & Goody, R. S. (1997) · Biochemistry · doi:10.1021/bi970512z · Cited by 147
Pandey, V. N., Kaushik, N., Rege, N., Sarafianos, S. G., Yadav, P. N., & Modak, M. J. (1996) · Biochemistry · doi:10.1021/bi9516642 · Cited by 134
Self-citationSeverini, A., Liu, X. Y., Wilson, J. S., & Tyrrell, D. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1430 · Cited by 133
Sarafianos, S. G., Das, K., Dingi, J., Boyer, P. L., Hughes, S. H., & Arnold, E. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80071-4 · Cited by 130
Self-citationBoyer, P. L., & Hughes, S. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1624 · Cited by 113
Self-citationGhosh, M. P., Jacques, P. S., Rodgers, D. W., Ottman, M., Darlix, J., & Grice, S. F. J. L. (1996) · Biochemistry · doi:10.1021/bi952773j · Cited by 96
Martín‐Hernández, A. M., Domingo, E., & Menéndez‐Arias, L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00816.x · Cited by 88
Kukhanova, M. K., Liu, S.-H., Mozzherin, D. J., Lin, T., Chu, C. K., & Cheng, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23055 · Cited by 87
Human Immunodeficiency Virus Type-1 Reverse Transcriptase
Wilson, J. E., AULABAUGH, A. E., Caligan, B., McPherson, S. A., Wakefield, J., Jablonski, S. A., Morrow, C. D., Reardon, J. E., & Furman, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13656 · Cited by 86
Jacques, P. S., Wöhrl, B. M., Ottmann, M., Darlix, J., & Grice, S. F. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47218-3 · Cited by 78
Wöhrl, B. M., Krebs, R., Thrall, S. H., Grice, S. F. J. L., Scheidig, A. J., & Goody, R. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17581 · Cited by 70
Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase
Sarafianos, S. G., Pandey, V. N., Kaushik, N., & Modak, M. J. (1995) · Biochemistry · doi:10.1021/bi00021a036 · Cited by 68
Self-citationUeno, T., & Mitsuya, H. (1997) · Biochemistry · doi:10.1021/bi962393d · Cited by 66
Faraj, A., Agrofoglio, L. A., Wakefield, J., McPherson, S. A., Morrow, C. D., Gosselin, G., Mathé, C., Imbach, J. L., SCHINAZI, R. F., & Sommadossi, J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2300 · Cited by 63
NAIR, V., Clair, M. H. S., Reardon, J. E., Krasny, H. C., Hazen, R. J., Paff, M. T., Boone, L. R., Tisdale, M., Nájera, I., & Dornsife, R. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1993 · Cited by 59
Competitive inhibitors of human immunodeficiency virus reverse transcriptase
Schinazi, R. F. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171660 · Cited by 50
Smith, R. A., Remington, K. M., Preston, B. D., Schinazi, R. F., & North, T. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2335-2340.1998 · Cited by 35
Smith, R. A., Remington, K. M., Lloyd, R. M., Schinazi, R. F., & North, T. W. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2357-2362.1997 · Cited by 34
Cited by
Clavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
Wang, J., Morin, P., Wang, W., & Kollman, P. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja003834q · Cited by 708
Sarafianos, S. G., Marchand, B., Das, K., Himmel, D. M., Parniak, M. A., Hughes, S. H., & Arnold, E. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.071 · Cited by 535
Self-citationDas, K., Clark, Lewi, P. J., Heeres, J., de Jonge, M. R., Koymans, L. M. H., Vinkers, H. M., Daeyaert, F., Ludovici, D. W., Kukla, M. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030558s · Cited by 514
Self-citationThe structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 424
Metadata
- Authors
- Sarafianos, S. G., Das, K., Clark, A. D., Ding, J., Boyer, P. L., Hughes, S. H., & Arnold, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-08-31
- Volume
- 96
- Issue
- 18
- Pages
- 10027-10032
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2119855246
- Cited by
- 309
- References
- 44
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.